Beyond regulatory delays: How patent misuse impacts access to affordable medications

This Globe and Mail op-ed calls attention to how brand-name manufacturers are using the patent system to block affordable biosimilars and generics in Canada.

This Globe and Mail op-ed calls attention to how brand-name manufacturers are using the patent system to block affordable biosimilars and generics in Canada.

In this video, science communicator Patrick Kelly uses engaging visuals and storytelling to explain the pharmaceutical patent system.

This infographic illustrates how trade agreements can increase drug prices by embedding extended intellectual property protections.

This TED Talk by Priti Krishtel expresses how lack of transparency and misuse of patent protections are key contributions to skyrocketing drug costs.